['glaucoma, open-angle', 'ocular hypertension']
['bimatoprost sustained-release', 'timolol', 'timolol vehicle (placebo)']

        Inclusion Criteria:

        - Diagnosis of either open-angle glaucoma or ocular hypertension in each eye and both eyes
        require IOP-lowering treatment.

        Exclusion Criteria:

          -  Previous enrollment in another Allergan Bimatoprost SR Study

          -  Eye surgery (including cataract surgery) and/or any eye laser surgery within the past
             6 months in the study eye

          -  Anticipated need for laser eye surgery within the first 52 weeks of the study duration

          -  History of glaucoma surgery
      